Literature DB >> 4027150

Nicardipine in models of myocardial infarction.

B J Alps, C Calder, A Wilson.   

Abstract

In a dog model of partial myocardial ischaemia, superimposed ST segment elevations in epicardial ECGs were inhibited by nicardipine over a cumulative i.v. dose range of 1-20 micrograms kg-1. Over the cumulative i.v. dose range of 0.5-166.5 micrograms kg-1, nicardipine had little overall effect on gross cardiac conduction, at spontaneous heart rate. Dogs that received oral 1-2 mg kg-1 nicardipine daily for 16 weeks and then survived 1 week occlusion of the left anterior descending coronary artery (LAD) developed a superior coronary collateral circulation compared with untreated animals. Nicardipine given by three different dosing schedules to baboons markedly limited myocardial infarction over a 6 h period of LAD occlusion. Compared with a group of completely untreated dogs, there was protection of the myocardium in the animals given nicardipine that survived 3 months occlusion of the LAD.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027150      PMCID: PMC1400792          DOI: 10.1111/j.1365-2125.1985.tb05142.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).

Authors:  T Takenaka; S Usuda; T Nomura; H Maeno; T Sado
Journal:  Arzneimittelforschung       Date:  1976

2.  Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.

Authors:  L D Hillis; J Askenazi; E Braunwald; P Radvany; J E Muller; M C Fishbein; P R Maroko
Journal:  Circulation       Date:  1976-10       Impact factor: 29.690

3.  Stimulation of the coronary collateral circulation by lidoflazine (R 7904).

Authors:  W K Schaper; R Xhonneux; A H Jageneau
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1965-11-04

4.  Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation.

Authors:  W F Lubbe; M Peisach; R Pretorius; K J Bruyneel; L H Opie
Journal:  Cardiovasc Res       Date:  1974-07       Impact factor: 10.787

5.  Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.

Authors:  T Baum; G Rowles; A T Shropshire
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

6.  Surface mapping of RS-T segment in acute myocardial infarction.

Authors:  D S Reid; L J Pelides; J P Shillingford
Journal:  Br Heart J       Date:  1971-05

7.  Calcium antagonists.

Authors:  W G Nayler
Journal:  Eur Heart J       Date:  1980-06       Impact factor: 29.983

8.  Nitroglycerin and dipyridamole on cardiac metabolism and dynamics in a new experimental model of angina pectoris.

Authors:  L Szekeres; V Csik; E Udvary
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

9.  Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; J E Lowe; R B Jennings
Journal:  Circulation       Date:  1977-04       Impact factor: 29.690

10.  Effects of verapamil on infarct size following experimental coronary occlusion.

Authors:  H J Smith; B N Singh; H D Nisbet; R M Norris
Journal:  Cardiovasc Res       Date:  1975-07       Impact factor: 10.787

View more
  3 in total

Review 1.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 2.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

3.  A comparison of the effects of a series of anti-anginal agents in a novel canine model of transient myocardial ischaemia.

Authors:  M C Allely; B J Alps
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.